Xenetic Biosciences, Inc. logo

XBIOXenetic Biosciences, Inc.

XBIO Stock Price, Valuation & Chart | Xenetic Biosciences, Inc.

Compare

XBIO Historical price chart

XBIO Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization9.74M
PE Ratio-3.54
EPS-1.2
Trading Volume24.81K
Today's High/Low4.43/4.16
Dividend Yield0.00
52 Week High/Low13.93/1.9
Shares Outstanding2.29M
XBIO Financial Statement
XBIO Analyst ratings
XBIO Analysis & performance metrics

XBIO Company profile

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to…

XBIO Management team

Management
James F. ParslowCEO
Chief Financial Officer, Chief Operating Officer, Interim Chief Executive Officer & Corporate Secretary
Total 1 executive

XBIO Frequently asked questions

What is Xenetic Biosciences, Inc. (XBIO) Stock Price?

Current stock price of Xenetic Biosciences, Inc. (XBIO) stock is $4.250. The stock price is +0.47% higher in the session. The intraday range can be seen from this page. Volume of Xenetic Biosciences, Inc. (XBIO) stock is 24.81K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Xenetic Biosciences, Inc. (XBIO) stock price going up or down today?

The stock price of Xenetic Biosciences, Inc. (XBIO) can change with earnings, company news, and overall market sentiment. Xenetic Biosciences, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Xenetic Biosciences, Inc. stock expensive at its current price?

Whether Xenetic Biosciences, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for XBIO on this page is -3.54. EPS on this page is -1.20. Compare those figures with peers and growth expectations before deciding if the current Xenetic Biosciences, Inc. price is justified.

How has the stock price of Xenetic Biosciences, Inc. (XBIO) performed historically?

Historical performance for Xenetic Biosciences, Inc. (XBIO) is shown on the price chart on this page. Review multi-period moves alongside volume to see how XBIO reacted to past earnings and market events.

Should I buy Xenetic Biosciences, Inc. (XBIO) stock, at this price?

Buying Xenetic Biosciences, Inc. (XBIO) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.